Uncategorized – Biotech Reporter

Our Lead Story Uncategorized
Medicenna Therapeutics (Nasdaq:MDNA) Raises $20M to Fast-Track Immunotherapy Pipeline

by Pat November 6, 2025

November 6, 2025
Uncategorized
Hemostemix (TSXV:HEM) Secures $3M Financing as Stem Cell Trial hits Key Milestone

by Pat November 4, 2025

November 4, 2025
Uncategorized
Docebo (TSX:DCBO) Pushes Into Generative AI As Canadian CEOs Prioritize Tech Investment

by Pat October 25, 2025

October 25, 2025
Uncategorized
NextCure (Nasdaq:NXTC) and Simcere Zaiming Announce First U.S. Patient Dosed in SIM0505 Phase 1 Trial

by Pat October 16, 2025

October 16, 2025
Uncategorized
Milestone (Nasdaq:MIST) Secures $125M To Advance Cardiovascular Drug Trials

by Pat October 16, 2025

October 16, 2025
Uncategorized
aTyr Pharma Announces Phase 3 EFZO-FIT™ Study Results for Efzofitimod in Pulmonary Sarcoidosis

by Pat September 15, 2025

September 15, 2025

1
2

About Us

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10 am ET Mon-Fri.

Contact Us

General Inquiries

info@biotechreporter.news

Submit News